|
⚲
|
| Keyboard |
| Shields Matthew
✚
|
|
|---|---|
| CIK # | 0002025621 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002025621] | |
| 4 | [0002025621] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Shields Matthew | |
| Teva Pharmaceutical Industries Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Option exercise | 17,295 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Sell | 17,295 | $31.67 | 547,733 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-05 | Option exercise | 17,295 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Grant | 33,424 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2025-06-03 | Option exercise | 16,195 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-06-03 | Sell | 6,206 | $17.02 | 105,626 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-06-03 | Option exercise | 16,195 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2025-03-05 | Grant | 69,182 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2024-06-03 | Grant | 64,782 | $0.00 |